John Lunger, Chief Patient Supply Officer at Adaptimmune Therapeutics PLC (ADAP), sold 9,229 shares at $0.85 ($8K) on 2024-01-12, disclosed to the SEC on 2024-01-12.
Seasonal sale ($8k) by Chief Patient Supply Officer — this insider has traded ADAP in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.84 | 4,009 | $3K | 43.1% |
| 2 | $0.85 | 5,220 | $4K | 56.9% |
| Total | $0.85 avg | 9,229 | $8K | 100% |
| Filing → |
| ADAP | SELL | 2024-01-17 | $16K | — | Filing → |
| ADAP | SELL | 2023-08-01 | $3K | — | Filing → |
| ADAP | SELL | 2023-01-17 | $8K | — | Filing → |